At the Medicap Pharmacy® stores, we are dedicated to providing products and services to care for your family’s wellness. One of those services is health news you can trust. Use the filters to focus on the information that is important to you, then bookmark this page to make it a regular stop anytime you’re online.
First Digital Medication Approved
Abilify MyCite is the first digital medication system approved by the US Food and Drug Administration (FDA).
First Tardive Dyskinesia Rx Approved
The US Food and Drug Administration (FDA) has approved the first drug to treat tardive dyskinesia.
A New Warning for Olanzapine
The US Food and Drug Administration (FDA) is warning about the possibility for a rare but serious skin reaction from a particular antipsychotic.
New Warning For Aripiprazole
The US Food and Drug Administration (FDA) is warning about possible impulse-control problems, such as compulsive or uncontrollable urges, tied to a particular antipsychotic.
Spotting the Treatment Gap in Diabetes Screening
Patients with severe mental illness face an increased risk for diabetes. And new evidence suggests there may be room for improvement when it comes to screening these patients for the condition.
Mental Health Rx Gets Go-Ahead
A newly approved medication could help some patients with serious mental health disorders.
Schizophrenia, Bipolar Disorder Rx Approved
DUBLIN and BUDAPEST, Hungary, Sept. 17, 2015 /PRNewswire/ -- Allergan plc (NYSE: AGN) and Gedeon Richter Plc. announced today that the U.S. Food and Drug Administration (FDA) has approved VRAYLAR™ (cariprazine) capsules, an atypical antipsychotic, for the acute treatment of manic or mixed episodes associated with bipolar I disorder and for treatment of schizophrenia in adults.
Among Teens, Antipsychotics May Be Too Common
Mental illness consists of an array of complex and hard-to-pin-down disorders, but avoiding misdiagnosis can be crucial to treating it properly.
Under Debate: Psychiatric Medications
Medications are often prescribed to treat mental conditions, but are they all they’re cracked up to be? Some have raised concerns that psychiatric medications may have overstated benefits and underreported harms.
First-Ever Generic Abilify Gets FDA Go-Ahead
Four pharmaceutical companies received approval today from the US Food and Drug Administration (FDA) to market generic versions of Abilify, an atypical antipsychotic drug.